WEE-family kinases in cancer: synthetic lethal interactions and drug discovery
Trends in Pharmacological Sciences · 2026
DOI: 10.1016/j.tips.2025.09.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026. Verfasst von Chaofan Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Moderni…. Hauptthemen laut MEDLINE: Protein-Tyrosine Kinases, Neoplasms, Cell Cycle Proteins, Protein Kinase Inhibitors. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Changjiang Scholar Program, Ministry of Education.
Abstract (Originalsprache)
The WEE-family kinases, WEE1 and PKMYT1, play critical roles in regulating the G2/M cell cycle checkpoint to maintain genomic stability. Cancer cells with DNA damage response (DDR) deficiencies become heavily reliant on WEE1 and PKMYT1 to avert mitotic catastrophe. This dependence creates a synthetic lethality vulnerability that offers a promising therapeutic strategy. While early WEE1 inhibitors faced challenges due to toxicity, next-generation highly selective agents are now advancing through clinical trials with improved safety and efficacy. Similarly, PKMYT1 inhibitors have emerged as a complementary approach, with several candidates under clinical evaluation. This review examines the evolving mechanistic basis of synthetic lethality, with emphasis on how targeted inhibition of WEE1 or PKMYT1 exploits DDR defects to selectively induce genomic instability in cancer cells. Furthermore, we highlight recent advances in selective WEE kinase inhibitors, discuss key challenges, and explore innovative strategies to accelerate their development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education,…
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Changjiang Scholar Program, Ministry of Education
- National Key Research and Development Program of China
Zitieren
APA
Wang, C., & Lu, X. (2026). WEE-family kinases in cancer: synthetic lethal interactions and drug discovery. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2025.09.005
Vancouver
Wang C, Lu X. WEE-family kinases in cancer: synthetic lethal interactions and drug discovery. Trends in Pharmacological Sciences. 2026. doi:10.1016/j.tips.2025.09.005
BibTeX
@article{Wang2026,
author = {Wang, Chaofan and Lu, Xiaoyun},
title = {WEE-family kinases in cancer: synthetic lethal interactions and drug discovery},
journal = {Trends in Pharmacological Sciences},
year = {2026},
doi = {10.1016/j.tips.2025.09.005}
}
EUVIMED